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Human T Regulatory Cells Can Use
the Perforin Pathway to Cause
Autologous Target Cell Death
pathogens, and also tumor cells. Although there are
several mechanisms by which these cells kill, the major
one is the perforin/granzyme pathway (Lieberman, 2003;
Russell and Ley, 2002). Dysregulation of this pathway
is associated with several human diseases, including
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Both subtypes of CD4 Treg cells control pathologicalSummary
processes, including graft versus host disease, autoim-
munity, and infections (Bluestone and Abbas, 2003; Dit-Cytotoxic T lymphocytes and natural killer cells use
tmer et al., 2004; Maloy and Powrie, 2001; Sakaguchithe perforin/granzyme pathway to kill virally infected
et al., 2001). Most of the work defining these regulatory
cells and tumor cells. Mutations in genes important
subsets has been carried out in murine models, and
for this pathway are associated with several human studies of human Treg cells are limited.
diseases. CD4 T regulatory (Treg) cells have emerged Several reports have indicated that natural Treg cells
as important in the control of immunopathological pro- exert their antiproliferative effects via a cell contact-
cesses. We have previously shown that human adap- dependent mechanism; however, the precise mecha-
tive Treg cells preferentially express granzyme B and nism(s) by which this effect is mediated remains to be
can kill allogeneic target cells in a perforin-dependent determined (Bluestone and Abbas, 2003; Sakaguchi et
manner. Here, we demonstrate that activated human al., 2001; Shevach, 2002). Since perforin/granzyme-
CD4CD25 natural Treg cells express granzyme A but mediated target cell death requires cell contact, we in-
very little granzyme B. Furthermore, both Treg sub- vestigated whether Treg cells are armed with cytotoxic
types display perforin-dependent cytotoxicity against granules. We have previously shown that adaptive Treg
autologous target cells, including activated CD4 and cells generated from human CD4 T cells by coligation
CD8 T cells, CD14 monocytes, and both immature of the T cell coreceptor CD3 and the complement regula-
and mature dendritic cells. This cytotoxicity is depen- tory protein CD46 in the presence of IL-2 express pre-
dent on CD18 adhesive interactions but is independent dominantly granzyme B (Grossman et al., 2004). These
of Fas/FasL. Our findings suggest that the perforin/ adaptive Treg cells demonstrated cytotoxicity against
granzyme pathway is one of the mechanisms that Treg allogeneic tumor cell lines in a perforin-dependent, but
cells can use to control immune responses. MHC/TCR-independent, manner.
In this report, we characterize the granzyme expres-
sion pattern in human Treg cells and show that activatedIntroduction
natural CD4CD25 Treg cells express predominantly
granzyme A. We demonstrate that both subtypes of TregThe innate and adaptive immune systems include cyto-
cells exhibit perforin-dependent cytotoxicity against atoxic T-lymphocytes (CTLs) and natural killer (NK) cells
variety of autologous target cells, including CD4 andthat can identify and kill cells infected with intracellular
CD8 T cells, CD14 monocytes, and dendritic cells.
Interestingly, activated CD4 and CD8 T cells were
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T cells. In addition, immature myeloid dendritic cells7 Present address: Department of Pediatrics, Division of Hematol-
were preferentially killed over LPS matured dendriticogy/Oncology, Medical College of Wisconsin, Milwaukee, Wiscon-
sin, 53226. cells by Treg cells. We found no involvement of the Fas/
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Fas ligand (FasL) pathway in the observed cytotoxicity, (Figure 2A). The observed killing was perforin depen-
dent, since cytotoxicity was abolished with the perforinbut selective inhibitors of perforin (e.g., EGTA and con-
canamycin A), as well as neutralizing antibodies against inhibitors EGTA and concanamycin A (Figure 2A; data
not shown). Blocking antibodies to CD18 were similarthe adhesive protein CD18, abrogated killing. These re-
sults establish that human natural and adaptive Treg to EGTA in their ability to inhibit cytotoxicity (Figure
2B), suggesting that adhesive immunological synapsecells can kill autologous target cells in a CD18 and per-
forin-dependent manner and suggest a role for the per- interactions are required for cytotoxicity. FasL neutraliz-
ing antibodies failed to prevent cytotoxicity in theseforin/granzyme pathway in immune regulation by Treg
cells. studies but were effective at neutralizing the cytotoxicity
by purified FasL against Jurkat cells, (Figures 2C and
2D). Interestingly, the purified FasL was unable to induceResults
significant cytotoxicity against U937 targets, which ex-
press high levels of surface Fas, suggesting that addi-Human Adaptive T Regulatory Cells Express
tional cellular requirements besides Fas expression areGranzyme B upon Activation and Exhibit
required for Fas/FasL induced cytotoxicity (Figure 2D)Perforin-Dependent Cytotoxicity
(Grossman et al., 2004).against Autologous Target Cells
We have previously shown that adaptive Treg cells are
Human Adaptive T Regulatory Cells Preferentially Killgenerated by stimulating CD4 T cells with antibodies
Autologous Immature Myeloid Dendritic Cellsto CD3/CD46 in the presence of IL-2 (Kemper et al.,
Because of the high level of cytotoxicity observed against2003). These adaptive Treg cells are highly proliferative,
freshly isolated autologous CD14 monocytes (Figuresecrete IL-10, and supernatants from adaptive Treg cells
2A) and myeloid tumor cell lines (Grossman et al., 2004),suppress naive T cell proliferation through the produc-
we tested the ability of adaptive Treg cells to inducetion of IL-10. We have recently demonstrated that these
the death of myeloid dendritic cells. CD14 monocytescells also express granzyme B and perforin and are able
were isolated from the same donor and cultured in theto kill allogeneic tumor cell lines in a perforin-dependent
presence of GM-CSF and IL-4 for 4 days to generatemanner (Grossman et al., 2004). An example of the flow
immature myeloid dendritic cells as previously de-cytometric profile of these cells is shown in Figure 1A.
scribed (Sallusto and Lanzavecchia, 1994). AdaptiveThese cells are large and granular, as reflected by con-
Treg cells were efficient at inducing the death of autolo-siderable forward and side scatter, respectively. As pre-
gous immature myeloid dendritic cells, with 80% ofviously established, these cells predominantly express
target cells incorporating 7-AAD after 4 hours of cocul-granzyme B (Figure 1A). The increase in cell size and
ture (Figure 3). In contrast, maturation of the myeloidgranularity of the adaptive Treg cells was confirmed by
dendritic cells with LPS for 24–36 hr significantly re-light microscopy, which also revealed an open nuclear
duced the percentage of 7-AAD positive cells. The ob-chromatin pattern (Figure 1B). Confocal immunofluores-
served killing was perforin- and CD18 dependent, sincecence confirmed the presence of granzyme B-con-
cytotoxicity was abolished by EGTA or blocking anti-taining granules (Figure 1C). Granzyme A expression by
bodies against CD18, while FasL blocking antibodiesadaptive Treg cells was not detected by flow cytometry
had no effect (Figure 3). To ensure that the addition ofor confocal immunoflourescence (Figures 1A and 1C).
LPS to mature dendritic cells had no effect on the adap-Since adaptive Treg cells kill allogeneic tumor cell
tive Treg cells, LPS was added to the killing assay, whichlines in a perforin-dependent (but MHC/TCR-indepen-
caused no reduction in cytotoxicity (data not shown).dent) manner (Grossman et al., 2004), we tested whether
these cells exhibited cytotoxicity against autologous tar-
gets. CD4 T cells were isolated and cultured with IL-2 Human CD4CD25 Natural T Regulatory Cells
Express Granzyme A after Activationalone or with antibodies to CD3/CD46 to generate adap-
tive Treg cells. Target cells consisted of purified CD4 Since adaptive Treg cells express granzyme B and were
cytotoxic against autologous targets, we tested whetherand CD8 T cells isolated from the same donor and
cultured for 4 days in IL-2 only or with plate bound natural CD425 Treg cells expressed a similar gran-
zyme profile under identical modes of stimulation. Hu-antibodies to CD3/CD28. Freshly purified autologous
CD14 cells were also used as target cells. Adaptive man CD4 T cells were purified from peripheral blood
by magnetic isolation, stained with antibodies againstTreg effector cells were cocultured with CFSE-labeled
target T cell subsets or CD14 monocytes at a 20:1 CD25, and then sorted to obtain CD4CD25 double-
positive natural Treg cells. Only the highest CD25-posi-effector to target ratio. Target cell death was analyzed
by flow cytometry by using 7-AAD incorporation and tive cells (2% of all CD4 cells; Figure 4A) were used
in these experiments, since this selective sorting is re-reduction in cell size as surrogate markers of cell death
(Dumitriu et al., 2001; Grossman et al., 2004; Lecoeur et quired to isolate natural Treg cells from human periph-
eral blood (Baecher-Allan et al., 2001). These flow-puri-al., 2001). CD4 T cells stimulated with IL-2 alone were
inefficient at killing autologous target cells (CD4, CD8, fied CD4CD25hi cells yielded a strong PCR signal for
the transcription factor FoxP3, while the CD4CD25and CD14 cells), consistent with their lack of granzyme
expression (data not shown) (Grossman et al., 2004). cell population yielded a substantially weaker signal
(Figure 4B).Adaptive Treg cells induced the death of autologous
activated CD4 and CD8 T cells, as well as freshly To further confirm that these CD4CD25hi cells ex-
hibit the characteristics of natural Treg cells, cocultureisolated CD14 monocytes, while resting CD4 and
CD8 T cell targets were relatively resistant to killing experiments were performed with autologous CD4CD25
Perforin/Granzymes in Human T Regulatory Cells
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Figure 1. Activation of Human CD4 T Cells with CD3/CD46 Antibodies to Generate Adaptive Treg Cells Results in the Expression of Granzyme
B, but Not Granzyme A
(A) Human CD4 T cells exhibit a differential increase in side-scatter (SSC)/granularity and forward scatter (FSC)/size when stimulated with
CD3/CD46  IL-2 versus IL-2 alone (top). Increased granularity in CD3/CD46 activated CD4 T cells corresponded with the expression of
granzyme A (middle), but not granzyme B (bottom).
(B) Light microscopic evaluation (1000) of adaptive Treg cells demonstrating their large size, abundant cytoplasm, cytoplasmic granules,
and open nuclear chromatin pattern, compared to CD4 T cells incubated in IL-2 only.
(C) Confocal immunofluorescence microscopy of adaptive Treg cells using specific monoclonal antibodies shows cytoplasmic granular staining
for granzyme B (red), but not granzyme A (green), in adaptive Treg cells, but not resting T cells. Cell size is indicated. Data shown are
representative of more than three independent donor samples. The cells shown in (C) are different from those in (A).
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Figure 2. Human Adaptive Treg Cells Exhibit Perforin-Dependent Cytotoxicity against Autologous T Cells and Monocytes
(A) Representative example of adaptive Treg cell cytotoxicity against autologous target cells. Adaptive Treg effector cells were cultured with
different autologous target cells at a 20:1 ratio for 4 hr, and the percentage of 7-AAD positive cells was measured. EGTA (4mM) was added
to target cells alone to control for EGTA toxicity.
(B) Neutralizing antibodies against CD18 abrogated adaptive Treg cell cytotoxicity similar to EGTA inhibition.
(C) FasL neutralizing antibodies failed to inhibit adaptive Treg cell cytotoxicity.
(D) Neutralizing FasL antibody abrogates cytotoxicity induced by recombinant human soluble FasL in a cell line susceptible to Fas/FasL
induced cytotoxicity (Jurkat). Also shown is the relative resistance of the U937 cell line to cytotoxicity by soluble FasL. Data shown is
representative of more than three independent donor samples. Values shown are the mean  SD. *p  0.05, **p  0.01, ***p  0.001.
cells. Stimulation of CD4CD25 cells with either CD3/ (data not shown) (Baecher-Allan et al., 2001). These re-
sults confirm that these CD4CD25hi cells exhibit theCD28 or CD3/CD46 in the presence of IL-2 (10–50 IU/
mL rhIL-2) resulted in a strong proliferative responses characteristics of natural Treg cells (Figure 4C).
We next stained these cells with antibodies to gran-(Figure 4C). In contrast, CD4CD25hi cells stimulated
under identical conditions showed little proliferation zyme A and B as previously described (Grossman et al.,
2004). Unstimulated natural Treg cells showed minimal(Figure 4C). However, inclusion of a larger percentage
of CD25 cells (i.e., top 3%–5% of CD4CD25 cells) granularity and no expression of either granzymes A or
B (Figure 5A). In contrast to the flow cytometry profileresulted in moderate proliferation (data not shown). When
CD4CD25hi cells were cocultured with CD4CD25 of CD3/CD46 generated adaptive Treg cells, stimulation
of natural Treg cells with plate bound antibodies to CD3cells, the proliferative response of CD4CD25 cells to
plate bound CD3/CD28 or CD3/CD46 was abolished. and CD46 in the presence of IL-2 induced a population
of cells that showed increased granularity (side scatter)Neutralizing antibodies to IL-10 had no effect on the
inhibition of proliferation by the CD4CD25hi cells but no significant increase in cell size (forward scatter).
This granular population also corresponded to a new(Figure 4C). Finally, flow cytometry of the isolated
CD4CD25hi cells showed them to express high levels population of CD4lo cells (Figure 5A). Staining with gran-
zyme-specific antibodies established that these granu-of L-selectin and CD45RO, consistent with prior reports
Perforin/Granzymes in Human T Regulatory Cells
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Figure 3. Human Adaptive Treg Cells Exhibit
Perforin-Dependent Cytotoxicity against Au-
tologous Myeloid Dendritic Cell Targets
Representative example of adaptive Treg cell
cytotoxicity against immature (iDC) and LPS
matured (mDC) autologous myeloid dendritic
cells showing resistance to cytotoxicity by
mDCs. mDCs were generated by culture of
iDCs with LPS for 36 hr prior to the killing
assay. Adaptive Treg cells and autologous
dendritic cells were incubated for 4 hr and
7-AAD incorporation measured. EGTA (4 mM),
neutralizing antibodies to FasL and CD18
were added to the killing assay. Effector to
target (E:T) ratios are shown. Data shown are
representative of more than three indepen-
dent donor samples. Values shown are the
mean  SD. **p  0.01, ***p  0.001.
lar, CD4lo cells expressed predominantly granzyme A cant target cell death occurred at very low effector:tar-
get ratios (i.e., 1:1), indicating potent cytotoxicity by(gate R2, Figure 5A). Similar results were seen when
these cells were stimulated with CD3/CD28 in the pres- the activated natural Treg cells (Figures 6A and 6B). In
contrast, when adaptive Treg cells were utilized in theence of IL-2, although the percentage of CD4lo cells
expressing granzyme A was reduced compared with killing assay at a 1:1 ratio, no significant cytotoxicity
was observed (data not shown). CD3/CD28 stimulatedCD3/CD46 stimulated cells (21% versus 85%, respec-
tively; Figure 5A). Light microscopic examination of natural Treg cells similarly killed autologous target cells
but less than that of CD3/CD46 stimulated natural TregCD3/CD46 stimulated natural Treg cells showed a slight
increase in cytoplasm, while the nuclear chromatin pat- cells (data not shown).
Autologous dendritic cells were also tested as targetstern remained condensed, similar to natural Treg cells
cultured in IL-2 alone (Figure 5B). Confocal immunofluo- of natural Treg cell killing. Both immature and mature
dendritic cells were incubated with natural Treg cellsrescence microscopy confirmed the presence of gran-
ules containing granzyme A, but not granzyme B (Figure as described above, and cytotoxicity was measured.
Interestingly, natural Treg cells exhibited cytotoxicity5C). Furthermore, these cells were shown to be viable
(i.e, they excluded 7-AAD and were not apoptotic by against both immature and mature dendritic cells, and
similar to adaptive Treg cell killing, immature dendriticmorphological criteria; data not shown; Figure 5B).
cells were more susceptible to cytotoxicity than mature
dendritic cells (Figure 6C). However, the effectiveness
Human CD4CD25 Natural T Regulatory Cells of dendritic cell killing was much lower by natural Treg
Exhibit Perforin-Dependent Cytotoxicity cells compared to adaptive Treg cell killing (35% versus
against Autologous Target Cells versus 75%, respectively; Figures 6C and 3). Both EGTA
Given the induction of granzyme A in stimulated natural and neutralizing antibodies to CD18 were able to abro-
Treg cells, we tested their ability to kill a variety of autolo- gate the observed cytotoxicity to near background lev-
gous target cells. Natural Treg cells were isolated by els (Figure 6C). Finally, CD3/CD28-stimulated natural
flow cytometry and cultured for 4 days with IL-2 only or Treg cells were significantly less effective at killing autol-
with plate bound antibodies to CD3/CD46, then used as ogous immature dendritic cells than CD3/CD46-stimu-
effector cells in a flow-based killing assay. Although lated natural Treg cells (Figure 6C; different donor than
unstimulated natural Treg cells exhibited minimal cyto- depicted in Figure 5A).
toxicity (Figure 6A), stimulated natural Treg cells were
capable of killing purified autologous CD4, CD8, and
CD14 target cells (Figure 6A). This killing was shown Discussion
to be perforin dependent, since the perforin inhibitors
EGTA and concanamycin A abrogated nearly all cytotox- In this report we demonstrate different patterns of gran-
zyme A and B expression in human Treg cell subsets.icity (Figure 6A; data not shown). CD3/CD28 activated
autologous CD4 and CD8 T cell targets were more Upon activation, CD4CD25 natural Treg cells predom-
inantly express granzyme A, while adaptive Treg cellsefficiently killed than target cells cultured in IL-2 alone
(Figure 6A). Neutralizing antibodies to FasL failed to express granzyme B. Both Treg cell populations are
highly granular, as determined by flow cytometry (sideinhibit cytotoxicity (Figure 6B). However, neutralizing an-
tibodies to CD18 blocked cytotoxicity as effectively as scatter) and confocal immunofluorescence studies.
Adaptive Treg cells proliferated vigorously and exhibitedEGTA (Figure 6A; data not shown). Interestingly, signifi-
Immunity
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Figure 4. Isolation and Characterization of Human Natural T Tegulatory Cells
(A) Representative FACS plot of purified human CD4 T cells demonstrating the gate used to sort CD4CD25 natural Treg cells and CD4CD25
T cells. All experiments were performed by using 2% of the highest CD25 expressing CD4 T cells.
(B) RT-PCR analysis for FoxP3 expression in flow-sorted CD4CD25 natural Treg cells and CD4CD25 T. -actin control lanes are shown
to the right for each sample to control for cDNA input, and RT indicates cDNA samples generated without reverse transcriptase.
(C) Coculture 3H-thymidine proliferation assay demonstrating suppression of autologous CD4CD25 T cell proliferation by CD4CD25 natural
Treg cells. Ratios of CD4CD25 natural Treg cells to CD4CD25 responder T cells were at 1:2 for all data points shown. Individual and
coculture samples were performed in the presence of plate bound anti-CD3/CD28 or anti-CD3/CD46 in the presence of IL-2 (10 U/mL).
Recombinant IL-10 (10 ng/mL) was able to inhibit CD425 T cell proliferation under both stimulation conditions, and neutralizing antibody
to IL-10 was able to abrogate the effect of exogenous IL-10. CD4CD25 natural Treg cells exhibit low proliferative capacity but are able to
inhibit the proliferation of CD4CD25 T cells. Neutralizing IL-10 antibodies had no effect on the suppression of CD4CD25 cells by CD4CD25
natural Treg cells.
a “blast-like” morphology, whereas activated natural allogeneic tumor cell line K562 (Grossman et al., 2004),
which lacks both MHC class I and class II expressionTreg cells did not proliferate or increase in size, and
their chromatin pattern remained condensed. We also (Day et al., 2003; Grossman et al., 2004). Second, the
effector Treg cells were not primed against their targetdemonstrate that both activated natural and adaptive
Treg cells exhibit perforin-dependent cytotoxicity against cells prior to the killing assay. Third, both Treg cell sub-
types effectively killed autologous target cells. Interest-autologous targets, including activated CD4 and CD8
T cells and dendritic cells. ingly, Rabinovich et al. (2003) recently reported that lym-
phokine-activated killer cells preferentially kill activatedAlthough the mechanism(s) by which the Treg cell
subsets recognize their targets is unclear, several lines autologous CD4 and CD8 T cells through a perforin/
NKG2D-dependent pathway. In addition, we demon-of evidence suggest that it is an MHC/TCR-independent
process, akin to NK cell target recognition. First, we strated that neutralizing antibodies against CD18, a criti-
cal component of immune synapses for both CD8 andhave previously shown that adaptive Treg cells kill the
Perforin/Granzymes in Human T Regulatory Cells
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Figure 5. Activation of Human Natural Treg Cells Results in the Expression of Granzyme A, but Not Granzyme B
(A) Natural Treg cells show an increase in granularity (SSC), but not size (FSC), when stimulated through CD3/CD46 (arrow). The granular
population (R2 gate) corresponds to a cell population expressing low surface CD4 and granzyme A, but not granzyme B (bottom/side panels).
CD3/CD28 stimulation of natural Treg cells results in a similar granular CD4lo population but with fewer granzyme A-expressing cells (bottom/
side panels).
(B) Light microscopic evaluation of CD4 T cells stimulated with IL-2 only and natural Treg cells stimulated with CD3/CD46. Pictures are
shown at 1000 magnification.
(C) Confocal immunofluorescence of CD3/CD46-activated natural Treg cells with specific monoclonal antibodies against granzyme A or
granzyme B shows cytoplasmic granular staining for granzyme A (green), but not granzyme B (red). Isotype antibodies controls and cell size




Figure 6. Human Natural Treg Cells Exhibit Perforin-Dependent Cytotoxicity against Autologous T Cells and Monocytes
(A) Representative example of natural Treg cell cytotoxicity against different autologous target cells at 4 hr. Cytotoxicity was preferential
against CD3/CD28-activated CD4 and CD8 target cells, as well as freshly isolated CD14 monocytes, and required activation of natural
Treg cells for cytotoxicity. EGTA (4 mM) added to target cells inhibited cytotoxicity by natural Treg cells.
(B) Neutralizing antibodies against FasL failed to block natural Treg cell cytotoxicity.
(C) Natural Treg cells exhibit cytotoxicity against autologous immature (iDC) and mature (mDC) dendritic cells, with iDC showing greater
susceptibility than mDCs to cytotoxicity. CD3/46 stimulation of natural Treg cells also demonstrated a significantly higher level of cytotoxicity
against target cells than CD3/CD28 stimulated natural Treg cells. Neutralizing antibodies against CD18 abrogated activated natural Treg cell
cytotoxicity similar to EGTA inhibition. Effector to target (E:T) ratios are shown. Data shown are representative of more than three independent
donor samples. Values shown are the mean  SD. *p  0.05, **p  0.01.
CD4 T cells (Somersalo et al., 2004), effectively abro- 2001; Hirst et al., 2003). PI-9 is also expressed in im-
mune-privileged sites such as the placenta, testis,gated cytotoxicity.
Target cell activation status and cell lineage also ap- ovary, and eye, which may offer these sites protection
from CTL induced damage (Bladergroen et al., 2001;pear to be important determinants of susceptibility to
killing, as demonstrated by our data which showed that Buzza et al., 2001; Hirst et al., 2001). While adaptive
Treg cells were very effective at causing the death ofactivated CD4 and CD8 T cells and immature myeloid
dendritic cells, were preferentially killed. Mature den- dendritic cells, natural Treg cells were much less effec-
tive. Although different E:T ratios were utilized, thesedritic cells and resting lymphocytes may lack surface
recognition receptors or, alternatively, may express in- results indicate that the killing of target cells by different
Treg cell populations does not represent nonspecifichibitors of the perforin/granzyme pathway to account
for their increased resistance to cytotoxicity (Figure 7). cytotoxicity but, rather, suggests that Treg subsets may
have differing potentials to kill specific target cell popu-It is known that mature dendritic cells express the en-
dogenous granzyme B inhibitor, PI-9 (Bladergroen et al., lations.
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The differential expression of granzymes A and B in
Treg subsets suggests that effector cell subtypes may
be armed with different granzymes to kill their target
cells. Our data also indicate that granzymes may pos-
sess different potencies in cytotoxicity, since granzyme
A expressing natural Treg cells were able to kill at a very
low E:T ratio (1:1), while granzyme B expressing adaptive
Treg cells exhibited cytotoxicity only at higher E:T ratios
(20:1). Since natural Treg cells preferentially express
granzyme A after stimulation, these cells may be re-
quired to suppress/kill activated autologous targets
cells that express endogenous inhibitors of granzyme
B, such as PI-9 (Figure 7) (Bird et al., 1998; Bird, 1998).
Initial proteomic data from our laboratory has shown
that there is minimal overlap between the cellular protein
targets of murine granzymes A and B, suggesting that
granzymes A and B induce target cell death by cleaving
non-overlapping sets of substrates (Bredemeyer et
al., 2004).
The mode of stimulation of natural Treg cells also
appears to affect their cytotoxic potential. As demon-
strated, CD3/CD46 stimulation was able to induce signif-
icantly more autologous target cell death than CD3/
CD28 stimulation, and the cytotoxic potential correlated
with the percentage of granzyme A-expressing natural
Treg cells. Examination of multiple donors has consis-
tently demonstrated significantly less cytotoxicity and
granzyme A expression by using natural Treg cells stim-
ulated with CD3/CD28 versus CD3/CD46. Although the
reasons are unclear, preliminary data suggests that in
the presence of plate bound CD46 antibodies, 10- to
100-fold less CD3 ligation is required to give similar
proliferative responses as seen with plate bound CD28
antibodies (J.W.V. and J.P.A., unpublished data). These
data suggest that CD46 lowers the threshold of T cell
Figure 7. Summary of Data Demonstrating the Differential Gran-
activation, which may explain the greater levels of gran-zyme Expression in Activated Human Natural and Adaptive Treg
zyme A expression and cytotoxicity observed in naturalCells and Their Cytotoxicity against Autologous Target Cells
Treg cells with CD3/CD46 compared to CD3/CD28 coli-Upon activation, natural Treg cells express primarily granzyme A,
gation. These data indicate that the full cytotoxic poten-whereas adaptive Treg cells express primarily granzyme B. Natural
Treg cells demonstrate a low proliferative capacity, while adaptive tial of natural Treg cells may not be obtained until the
Treg cells exhibit significant proliferation after stimulation. Autolo- height of an immune response, when the highest level
gous activated CD4 and CD8 T cells are preferentially killed over of immunoglobulin and complement deposition is ob-
unactivated T cells. Autologous immature myeloid dendritic cells served. It is at such a time that complement (C3b and
are also preferentially killed over matured myeloid dendritic cells.
C4b) attached to immune complexes would be able to
activate CD46 on natural Treg cells (Atkinson et al., 1994;
CD14 cells were also effectively killed in our studies, Kemper et al., 2003; Lindahl et al., 2000; Marie et al.,
providing evidence that Treg cells can kill autologous 2002; Riley-Vargus et al., 2004; Song, 2004).
cells of the myeloid lineage. In support of this, we and The lack of detectable proliferation of CD4CD25
others have previously shown that Jak3-deficient mice, natural Treg cells in the presence of exogenous IL-2
which lack CD4CD25 natural Treg cells, develop an stands in contrast to reports that showed partial restora-
expansion of the myeloid compartment with age (Antov tion of proliferation with exogenous IL-2 (200 and 500
et al., 2003; Grossman et al., 1999). In addition, FoxP3- IU/mL) (Dieckmann et al., 2001; Jonuleit et al., 2001),
deficient mice, which lack natural Treg cells, exhibit a while other reports show no effect with exogenous IL-2
similar expansion of myeloid cells (Talal Chatila, per- (100 IU/mL) (Levings et al., 2001). The reasons for the
sonal communication). Misra et al. (2004) showed that discrepancies between these studies and our report are
human CD425 T cells inhibit the maturation and func- not clear but may reflect the lower dose of IL-2 used
tion of immature myeloid dendritic cells through an un- in our studies (10–50 IU/mL versus 200–500 IU/mL). In
identified mechanism that was largely independent of addition, the natural Treg cells used in our studies are
IL-10 and TGF-. Although not specifically examined, likely to represent a very pure population of these cells,
their data are consistent with a cytotoxic effect of Treg since only the cells with the highest CD25 expression
cells on immature dendritic cells. Further experiments were used. Indeed, preliminary results from our labora-
will be required to determine if there are different effects tories indicate that as a larger percentage of CD25
of natural versus adaptive Treg cells on dendritic cell cells are included (i.e., 3%–5%), more proliferation is
observed under similar stimulatory conditions (data notdevelopment and function.
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shown). By using these less-stringent conditions of puri- Natural Treg cells have previously been shown to uti-
fication, we have noticed that the relative number of lize TGF- and CTLA-4 to mediate their suppressive
natural Treg cells (exhibiting low surface CD4 and gran- effects in in vitro coculture experiments, although the
zyme A expression) decreases, and suppression is over- results are conflicting (Gavin and Rudensky, 2003;
come by the larger number of “nonnatural” Treg cells Kingsley et al., 2002; Levings et al., 2002; Nakamura et
(data not shown). One reason for these differences in al., 2001; Piccirillo et al., 2002; Shevach, 2002). In addi-
proliferation may be the higher basal expression of the tion, recent data has shown that a CD4CD25 cell line is
transcriptional factor FoxP3 in natural Treg cells, which able to exhibit cytotoxicity against B cells in an antigen-/
has been shown to prevent cytokine production and MHC class II-specific manner that is partly mediated
proliferation of T cells (Ramsdell, 2003; Schubert et through FasL (Janssens et al., 2003). While these mecha-
al., 2001). nisms of suppression are likely to be important, we pro-
A potential role of the perforin/granzyme pathway in pose that an additional mechanism of suppression by
the regulation of immune responses was first suggested natural Treg cells is mediated by the killing of autologous
by the discovery of perforin mutations in patients with cellular targets through a perforin/granzyme-depen-
hemophagocytic lymphohistiocytosis (HLH) (Stepp et dent pathway.
al., 1999). HLH is a disease in which the immune system
becomes overactive due to its inability to effectively
Experimental Procedures
clear infections and/or shutdown the immune response
to such infections. Untreated HLH patients develop end- Cell Isolation and Stimulation
organ damage from lymphocyte infiltration and macro- Human peripheral blood samples were collected from healthy do-
nors in accordance with protocols approved by the Washingtonphage activation. All of the known mutations associated
University School of Medicine Human Studies Committee and Inter-with HLH (e.g., Perforin, SAP, Munc13-4, Rab27a,
nal Review Board. Peripheral blood mononuclear cells (PBMCs)CHS-1, RGGT, and others) affect genes that are impor-
were obtained by using Ficoll-Paque (Amersham). For preparationtant in the granule exocytosis pathway, implicating its
of adaptive Treg cells, human PBMCs were positively selected with
importance for controlling immune responses (Allen et anti-CD4 antibodies (OKT4; ATCC), then isolated with magnetically
al., 2001; Feldman et al., 2003; Menasche et al., 2000; labeled goat-anti-mouse antisera according to manufacturer’s in-
Russell and Ley, 2002; Stepp et al., 1999; Stinchcombe structions (Miltenyi Biotec). CD4 lymphocytes were routinely98%
pure as determined by flow cytometry. Similar results were obtainedet al., 2004). Perforin-deficient mice develop a disease
with positive selection by using anti-CD4 microbeads (Miltenyi Bio-that is similar to HLH if challenged with viruses. An
tec). Purified CD4 lymphocytes were cultured on plates coatedoveractive virus-specific T cell response leads to death
with antibodies to CD3 (OKT3 or Hit3a, Pharmingen) or CD46
within weeks of viral challenge (Badovinac et al., 2003; (TRA-2-10) in complete RPMI containing 10 U/mL rhIL-2 as pre-
Clark et al., 1995; Jordan et al., 2004; Matloubian et al., viously described (Kemper et al., 2003). Purified autologous target
1999). Depletion of CD8 T cells reduces their mortality, cells were isolated in a similar fashion utilizing antibodies against
CD4 (OKT4, ATCC; or anti-CD4 microbeads, Miltenyi Biotec), CD8suggesting that antigen-activated CD8 T cells cause
(OKT8; ATCC), and CD14 (60bca; ATCC). Target cells were culturedtissue damage and death (Badovinac et al., 2003). Simi-
in IL-2 with or without plate bound CD3/CD28 as described abovelarly, Murakami et al. (2002) have shown that natural
for the same period as effector cells.Treg cells help control the expansion of CD8 cells in
mice. Excessive immune suppression by natural Treg
Intracellular Granzyme Staining and Flow Cytometrycells may also have deleterious consequences, since
1 106 cells were washed and resuspended in staining buffer (PBS,Treg cells have been recently shown to contribute to
1% human albumin [Aventis Behring L.L.C.], 0.2g/L human immu-viral persistence by suppressing virus-specific CD8
noglobulin [Gammaguard; Baxter Healthcare]. Samples were la-T cells in a mouse model (Dittmer et al., 2004). beled with antibodies (Per-CP- and/or FITC-conjugated antibodies
The perforin/granzyme pathway may also be relevant against cell surface markers (anti-human CD4 [Becton Dickinson-
for the prevention of autoimmunity, as supported by Pharmingen]). Samples were fixed, permeabilized (Cytofix/Cyto-
evidence from the experimental autoimmune encepha- perm containing 0.2 g/L of human immunoglobulin; Pharmingen),
and stained with primary-conjugated anti-granzyme A antibodylomyelitis (EAE) model in which the absence of perforin
(CB9; Becton Dickinson-Pharmingen) diluted at 1:100 in staining(but not Fas/Fas ligand) led to a more severe form of
buffer and/or primary-conjugated anti-granzyme B antibody (GB12;EAE in several murine strains (Malipiero et al., 1997).
Caltag) diluted at 1:400 in staining buffer. Samples were analyzed
We have extended these observations with granzyme on a FACScan (Becton Dickinson). All FACS scans depicted are
B knockout mice, which also display a more severe form representative of three or more donors. Anti-granzyme A and anti-
of EAE (J. Russell and T.J.L., unpublished data). These granzyme B antibodies were analyzed for antigen specificity by
in vivo data suggest a role of the perforin/granzyme competitive assays by using recombinant granzyme A (Kamiya Bio-
medical Co.) and/or granzyme B proteins (Pham et al., 1998) (10:1pathway in controlling immune responses through the
molar ratio), as well as knockout mouse staining assays (Grossmankilling of multiple types of autologous immune cells. In
et al., 2004).addition, although natural Treg cells may have a rela-
tively low abundance in human peripheral blood (1%)
and exhibit a low proliferative capacity after stimulation, Isolation of Natural (CD4CD25) Treg Cells
CD4 T cells were isolated as described above and then stainedthe fact that these cells have been found to be dysfunc-
with anti-CD4-PE and anti-CD25-APC antibodies (Becton Dickin-tional in the life-threatening autoimmune disorder IPEX
son-Pharmingen). Natural CD4CD25 circulatory Treg cells were(Immunodysregulation/Polyendocrinopathy/Entero-
isolated on a MoFlo cytometer (Cytomation, Inc.). Only high CD25-
pathy/X linked; a syndrome lacking natural Treg cells expressing cells (2% total CD4 T lymphocytes) were used for
due to a deficiency in FoxP3) suggests that they are analysis. CD4CD25hi Treg cells were used immediately (unstimu-
clearly important for the control of normal immune re- lated) or were stimulated with anti-CD3/CD46 coated plates for 4
days before analysis of intracellular Granzyme A and B expression.sponses (Chatila et al., 2000).
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RT-PCR Analysis for FoxP3 Expression 1:4). FloKA assays were compared to standard chromium release
assays and gave similar results (data not shown) (Lecoeur et al.,CD4CD25hi T cells or CD425T cells were isolated by cell sorting,
and total RNA was isolated from equal number of cells (Qiagen). 2001). To control for the ability of the FasL neutralizing antibody to
inhibit Fas/FasL-induced cytotoxicity, recombinant purified solubleReverse transcription of total RNA was performed by using the
IMPROM RT system (Promega). PCR analysis was performed with FasL (PeproTech, NJ, USA; 25 ng/mL) with or without neutralizing
FasL antibody (40 g/mL; NOK1, Beckton Dickinson-Pharmingen),the following FoxP3 specific primers: 5	-AGGAVTTCVTCAAGCACT
GCCAG-3	 and 5	-TCCGTTTCTTGCGGAACTCC-3	. Human -actin was used against a known susceptible cell line (Jurkat; ATCC) or a
human cell line expressing high levels of surface Fas (U937; ATCC)specific primers were as follows: 5	-TGGCATCGTGATGGACTCT
GGT-3	 and 5	-ATGGCCATCTCCTGCTCGGAGT-3	. PCR conditions (Grossman et al., 2004). All cytotoxicity assays were performed in
duplicate. Data presented are representative of three or more indi-included a 94
C hot start for 2 min, followed by 40 cycles as follows:
denaturing at 94
C for 30 s, annealing at 60
C for 30 s, and extension vidual cytotoxicity experiments. Statistical analyses were performed
by one-way ANOVA with Bonferroni posttest analysis, or Student’s tat 72
C for 2 min. Samples were run on a 1% agarose gel with a 1 kb
molecular weight marker (New England Biolabs). Negative controls test by using GraphPad Prism version 3.0a for Macintosh (GraphPad
Software, San Diego).consisted of RNA from CD4 T cells without RT enzyme. PCR prod-
ucts were sequenced and shown to be specific for FoxP3 (data
not shown). Light Microscopy and Confocal Immunofluorescence
Unstimulated (IL-2 only) and stimulated (CD3/CD46) sorter-purified
CD4CD25 or CD4CD25 T cells were cytospun (300 rpm for 33H-Thymidine Proliferation/Coculture Assays
min; Shandon) onto glass slides. Cells were then stained with stan-Proliferation assays were performed as previously described (Gep-
dard May-Gru¨nwald/Giemsa stain (Sigma). Light microscopy pic-pert and Lipsky, 1988). Briefly, CD4CD25 T cells and CD4CD25
tures were taken with a Nikon microscope (original magnificationTreg cells were isolated as described above. Cell samples (1  105)
for all light microscopy pictures, 1000). For immunofluorescencewere seeded into flat-bottom, 96-well plates (Corning) that were
of different cell types, cells were cytospun onto slides as indicatedcoated with anti-CD3 antibodies with either anti-CD28 or anti-CD46
above. Samples were fixed, permeabilized (Cytofix/Cytoperm Bec-antibodies, or vehicle only (see above). Cocultures of CD4CD25
ton Dickinson-Pharmingen), and costained for 30 min with FITC-T cells and CD4CD25 Treg cells were performed at 2:1 ratios for
conjugated anti-granzyme A antibody (CB9; Becton Dickinson-Phar-all experiments shown. IL-10 (10 ng/mL) was added as a control
mingen) diluted at 1:100, along with RPE-conjugated anti-granzymefor inhibition of naive T cell proliferation. Control neutralizing IL-
B antibody (GB12; Caltag) diluted at 1:200 in permeabilization buffer10 antibody (10 g/mL, JES3-9D7, BD-Pharmingen) was added to
(containing 0.2 g/L of human immunoglobulin; CytoPerm Bectonassess the role of IL-10 production in the observed suppression.
Dickinson-Pharmingen). Isotype FITC- and RPE-conjugated controlAll samples were incubated in RPMI containing IL-2 for 4 days, at
antibodies were used in a similar manner. Confocal immunofluores-which time 3H-thymidine (1 Ci total; MP Biomedicals) was added
cence pictures were taken on a Zeiss LSM510 microscope (63 oilto each well and allowed to incubate for an additional 16 hr before
lens, NA1.4), with scales depicted in each picture.cells were isolated on glass filters (Baxter) and analyzed on a scintil-
lation counter. All samples were performed in duplicate or triplicate.
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